Growth Hormone Resistance of Beta-cells in Women With Gestational Diabetes Mellitus

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The purpose of the research study is to better understand how beta-cells (cells in the pancreas that make insulin and help regulate blood sugar) respond to growth hormone in people with a personal history of gestational diabetes (high blood sugar in pregnancy) at the University of Missouri. The aim of the study is to advance understanding of how growth hormone affects beta-cells and risk factors for developing gestational diabetes and type 2 diabetes.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: t
View:

• Singleton, full term pregnancy within the past 5 years

• Hemoglobin HbA1c ≤5.6% and fasting blood glucose \<100 mg/dl

• Body mass index ≥30.0 kg/m2 and \<45.0 kg/m2, because the majority of women with GDM have overweight/obesity

⁃ Group specific inclusion criteria:

• Gestational Diabetes Group: History of gestational diabetes in the most recent pregnancy

• Control Group: no history of gestational diabetes

Locations
United States
Missouri
University of Missouri School of Medicine
RECRUITING
Columbia
Contact Information
Primary
Amanda Heider
ahmc4@health.missouri.edu
573-884-6852
Backup
Vasavi Shabrish, PhD
v.shabrish@missouri.edu
Time Frame
Start Date: 2025-08-30
Estimated Completion Date: 2030-09-01
Participants
Target number of participants: 30
Treatments
Women with a history of gestational diabetes mellitus
Women without a history of gestational diabetes mellitus
Sponsors
Leads: University of Missouri-Columbia

This content was sourced from clinicaltrials.gov